Eletriptan Shortage Update: What Patients Need to Know in 2026

If you've been searching online for an "eletriptan shortage" or "Relpax shortage" and landed here, here's the quick answer: as of 2026, eletriptan is NOT on the FDA's official Drug Shortage Database. Generic eletriptan has been available since 2017, and multiple manufacturers supply the market, so there is no nationwide manufacturing crisis.

That said, many patients are still struggling to get eletriptan filled reliably. The reasons are worth understanding — because knowing the real cause of your access problem leads to the right solution.

Current Eletriptan Availability Status (2026)

FDA Shortage List: Not listed as of 2026

Generic Availability: Available since 2017; multiple generic manufacturers

Strengths Available: 20 mg and 40 mg oral tablets

Brand Relpax: Still marketed by Pfizer; available but significantly more expensive

Controlled Substance: No — eletriptan is not a controlled substance, so no DEA quota limitations

Has Eletriptan Ever Been in a Shortage?

Eletriptan has not had a widely documented nationwide shortage on the FDA shortage list. During the COVID-19 pandemic, some medications experienced sporadic supply chain issues, and localized availability gaps have been reported, but eletriptan has generally remained on the market without formal shortage designation.

Some patients confuse difficulty filling a prescription with a drug shortage. The distinction matters: a shortage is a supply problem at the manufacturer level. Most eletriptan access issues in 2026 are insurance and pharmacy stocking problems — not manufacturing problems.

Why Some Patients Still Can't Get Eletriptan in 2026

Here are the most common real-world access barriers:

Insurance Quantity Limits

Most insurance plans limit triptans to 4–9 tablets per month. Eletriptan, which typically sits at a higher formulary tier than sumatriptan, often gets the lowest quantity limits — sometimes just 4 tablets/month. For patients with frequent migraines, this is simply not enough.

Step Therapy Requirements

Some insurance plans require you to try and fail on a cheaper triptan — usually sumatriptan — before they'll cover eletriptan. If your doctor prescribes it as first-line, the prescription may be flagged for prior authorization, causing delays and confusion at the pharmacy.

Local Pharmacy Stocking

Not every pharmacy stocks every triptan in every strength. Chain pharmacies use demand-based inventory systems. A location that fills few eletriptan prescriptions may not maintain stock of both 20 mg and 40 mg tablets, particularly 20 mg, which is less commonly prescribed.

What Patients Should Do Right Now

Check your insurance coverage. Log into your plan portal or call the pharmacy benefits number on your insurance card to confirm whether eletriptan is on your formulary and what your quantity limit is.

Get a GoodRx coupon. Even if your insurance covers eletriptan, GoodRx can bring the cost of generic eletriptan down to $21–$25 for 6 tablets at many pharmacies. This is useful for filling additional quantities beyond your insurance limit.

Use medfinder to find stock. If your regular pharmacy is out of stock, medfinder contacts pharmacies near you to find which ones currently have eletriptan available.

Talk to your doctor about a backup plan. If eletriptan access remains unreliable, your doctor can prescribe a second triptan as a backup or discuss preventive therapy to reduce how many doses you need per month.

Looking Ahead: Will Eletriptan Availability Change?

Eletriptan's long patent expiration (original patents expired in 2016) means the generic market is mature. More manufacturers, not fewer, typically enter the market over time, which generally improves availability and lowers prices further. There is no foreseeable reason for a formal shortage in 2026.

For a deeper look at what drives eletriptan access issues, read why eletriptan is hard to find. And if you need help locating your medication right now, medfinder can help.